CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Grant or award Chief Scientific Officer acquired 4,375 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 4,375 shares (grant or award)
- 4 Grant or award See Remarks acquired 4,375 shares (grant or award)
- 8-K Event Other events
- 8-K Event Other events
- 4 Option exercise Director acquired 1,693 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 68 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 68 shares (option exercise)
- 4 Option exercise CEO and President acquired 382 shares (option exercise)
- 4 Option exercise See Remarks acquired 68 shares (option exercise)
- 4 Option exercise Director acquired 1,693 shares (option exercise)
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 1,693 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement
- 424B5 Offering Prospectus
Page 6 of 34 · 672 filings